(Q74346082)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997814%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

Low-dose continuous chemotherapy (LBCMVD-56) for refractory and relapsing lymphoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997814%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997814%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

John Apostolidis

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997814%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

J Shamash

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997814%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

A M Wilson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997814%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

J M Foran

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997814%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

R K Gupta

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997814%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

A Z Rohatiner

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997814%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

S M Kelsey

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997814%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

T A Lister

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997814%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 July 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997814%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997814%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997814%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997814%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

857-860

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997814%20AND%20SRC:MED&resulttype=core&format=json

Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008355417445

7 January 2021

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008355417445

7 January 2021

Patterns of survival in patients with recurrent follicular lymphoma: a 20-year study from a single center

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008355417445

7 January 2021

Vinblastine, bleomycin, and methotrexate: an effective adjuvant in favorable Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008355417445

7 January 2021

Vinblastine for recurrent Hodgkin's disease following autologous bone marrow transplant

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008355417445

7 January 2021

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008355417445

7 January 2021

Clinical trials with an anti-CD25 ricin A-chain experimental and immunotoxin (RFT5-SMPT-dgA) in Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008355417445

7 January 2021

Treatment of refractory Hodgkin's disease with an anti-CD16/CD30 bispecific antibody

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008355417445

7 January 2021

Methyl-GAG, ifosfamide, methotrexate and etoposide (MIME) as salvage therapy for Hodgkin's disease: a prospective study.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008355417445

7 January 2021

EPIC: an effective low toxicity regimen for relapsing lymphoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008355417445

7 January 2021

Identifiers

DOI

10.1023/A:1008355417445

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997814%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference